Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Asociación para Evitar la Ceguera en México |
---|---|
Information provided by: | Asociación para Evitar la Ceguera en México |
ClinicalTrials.gov Identifier: | NCT00407121 |
Intravitreal injection of Bevacizumab in patients with Neovascular Membranes secondary to intraocular inflammation. We injected a single injection of Bevacizumab (2.5 mg/0.1 ml) and evaluate visual acuity , Fluorescein angiogram and retinal thickness by Optical Coherence Tomography (OCT) in 4 patients with Vogt Koyanagi Harada disease, 1 patient with Serpiginous Choroidopathy and 1 patient with Multifocal Choroiditis.
Condition | Intervention | Phase |
---|---|---|
Vogt Koyanagi Harada Disease Serpiginous Choroiditis Multifocal Choroiditis |
Drug: Bevacizumab Procedure: Intravitreal Injection of Bevacizumab |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Intravitreal Bevacizumab for the Treatment of Neovascular Membranes in Patients With Intraocular Inflammation |
Ages Eligible for Study: | 25 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Mexico, Distrito Federal | |
Asociacion para Evitar la Ceguera en Mexico | |
Mexico, Distrito Federal, Mexico, 04030 |
Principal Investigator: | Veronica Kon-Jara, MD | Asociacion para Evitar la Ceguera en Mexico |
Study Chair: | LuzElena Concha-Del Rio, MD | Asociacion para Evitar la Ceguera en Mexico |
Study ID Numbers: | APEC-0025 |
Study First Received: | December 1, 2006 |
Last Updated: | December 1, 2006 |
ClinicalTrials.gov Identifier: | NCT00407121 |
Health Authority: | National Institute of Public Health: Health Secretariat |
Neovascular Membrane Uveitis Bevacizumab |
Panuveitis Uveomeningoencephalitic Syndrome Autoimmune Diseases Uveitis, Posterior Eye Diseases Choroid Diseases Central Nervous System Diseases Bevacizumab |
Inflammation Multifocal choroiditis Central Nervous System Infections Uveitis Choroiditis Vogt-Koyanagi-Harada syndrome Autoimmune Diseases of the Nervous System |
Uveal Diseases Immune System Diseases Antineoplastic Agents Therapeutic Uses Growth Substances Physiological Effects of Drugs |
Meningoencephalitis Nervous System Diseases Growth Inhibitors Angiogenesis Modulating Agents Angiogenesis Inhibitors Pharmacologic Actions |